Literature DB >> 29676087

[Anti-breast cancer mechanism of flavonoids].

Bai-Bing Pang1, Yuan-Kui Chu1, Hua Yang1.   

Abstract

Flavonoids are a kind of ubiquitous natural products in plants and essential active ingredients of many medicinal plants. They have the characteristics of broad biological activity, high efficiency and low toxicity, with good prevention and cure effects on various types of tumors. Breast cancer is the commonest cancer disease and the main cause of cancer death in women worldwide. In China, the morbidity and mortality are still on the rise. Flavonoids can inhibit the occurrence and development of breast cancer in various aspects. The main mechanisms include the inhibition of aerobic glycolysis, the promotion of apoptosis, the retardation of cell cycle, the suppression of invasion and migration, the induction of DNA damage, and the inhibition of aromatase and microtubule production. Due to its chemical structure similar to estrogen, flavonoids have unique advantages in the prevention and treatment of breast cancer. In this paper, studies on anti-breast cancer of flavonoids in recent years were reviewed, which could provide reference for further studies. Copyright© by the Chinese Pharmaceutical Association.

Entities:  

Keywords:  apoptosis ; breast cancer ; flavonoids ; invasion

Mesh:

Substances:

Year:  2018        PMID: 29676087     DOI: 10.19540/j.cnki.cjcmm.20171211.005

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  3 in total

1.  Based on BATMAN-TCM to Explore the Molecular Mechanism of Xihuang Pill Regulating Immune Function to Treat Breast Precancerous Lesions.

Authors:  Dehui Li; Huanfang Fan; Jingfei Dong; Chunxia Sun; Yifan Su; Jiao Liu; Yiting Gu
Journal:  Breast Cancer (Dove Med Press)       Date:  2021-12-23

2.  Discovery of the natural product 3',4',7,8-tetrahydroxyflavone as a novel and potent selective BRD4 bromodomain 2 inhibitor.

Authors:  Jiao Li; Wei Zou; Koukou Yu; Bing Liu; Weifeng Liang; Lisha Wang; Yin Lu; Zequn Jiang; Aiyun Wang; Jiapeng Zhu
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

3.  Liquiritigenin decreases tumorigenesis by inhibiting DNMT activity and increasing BRCA1 transcriptional activity in triple-negative breast cancer.

Authors:  Fang Liang; Hao Zhang; Hui Gao; Duo Cheng; Nan Zhang; Jie Du; Junmin Yue; Peng Du; Beibei Zhao; Lu Yin
Journal:  Exp Biol Med (Maywood)       Date:  2020-09-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.